PE17098A1 - Nuevas sulfonamidas - Google Patents
Nuevas sulfonamidasInfo
- Publication number
- PE17098A1 PE17098A1 PE1996000714A PE00071496A PE17098A1 PE 17098 A1 PE17098 A1 PE 17098A1 PE 1996000714 A PE1996000714 A PE 1996000714A PE 00071496 A PE00071496 A PE 00071496A PE 17098 A1 PE17098 A1 PE 17098A1
- Authority
- PE
- Peru
- Prior art keywords
- formula
- phenyl substituted
- substituted
- refers
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: "X" e "Y" SON OXIGENO o AZUFRE; "Z" ES H, ALQUILO INFERIOR O ARILO, ENTRE OTROS; Ra PREFERENTEMENTE ES H o OH; Rb PREFERENTEMENTE ES H; n ES 0 o 1; "A" ES C(O)R3, EN DONDE R3 ES OH, ALCOXILO INFERIOR O -NR4R5, EN DONDE: R4 PREFERENTEMENTE ES H, Y R5 PREFERENTEMENTE ES TETRAZOLILO; R1 PREFERENTEMENTE ES FENILO SUSTITUIDO CON 4-TERC-BUTIL o 4-METOXI O ES PIRIDINO SUSTITUIDO CON 5-ISOPROPIL; R2 ES FENILO SUSTITUIDO CON METOXI O HALOGENO. TAMBIEN SE REFIERE AL COMPUESTO INTERMEDIO DE FORMULA (II), EN DONDE: "A" ES FORMILO o FURAN-2-ILO. ADEMAS SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE (I). LOS COMPUESTOS OBTENIDOS ACTUAN COMO INHIBIDORES DEL RECEPTOR DE LA ENDOTELINA, UTILES EN EL TRATAMIENTO DE TRANSTORNOS CIRCULATORIOS TALES COMO HIPERTENSION, ISQUEMIA, VASOESPASMOS Y ANGINA PECTORIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH289395 | 1995-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE17098A1 true PE17098A1 (es) | 1998-04-15 |
Family
ID=4243971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1996000714A PE17098A1 (es) | 1995-10-12 | 1996-10-09 | Nuevas sulfonamidas |
Country Status (28)
Country | Link |
---|---|
US (1) | US5856484A (es) |
EP (1) | EP0768304B1 (es) |
JP (1) | JP2723496B2 (es) |
CN (1) | CN1115339C (es) |
AR (1) | AR004215A1 (es) |
AT (1) | ATE217867T1 (es) |
AU (1) | AU706748B2 (es) |
BR (1) | BR9605046B1 (es) |
CA (1) | CA2187130C (es) |
CO (1) | CO4770959A1 (es) |
CZ (1) | CZ260596A3 (es) |
DE (1) | DE59609225D1 (es) |
DK (1) | DK0768304T3 (es) |
ES (1) | ES2175006T3 (es) |
HU (1) | HUP9602748A3 (es) |
IL (1) | IL119371A (es) |
MA (1) | MA23980A1 (es) |
MX (1) | MX9604762A (es) |
NO (1) | NO308000B1 (es) |
NZ (1) | NZ299519A (es) |
PE (1) | PE17098A1 (es) |
PL (1) | PL316486A1 (es) |
PT (1) | PT768304E (es) |
SG (1) | SG46753A1 (es) |
TR (1) | TR199600778A2 (es) |
TW (1) | TW438779B (es) |
UY (1) | UY24346A1 (es) |
ZA (1) | ZA968451B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ260596A3 (en) * | 1995-10-12 | 1997-12-17 | Hoffmann La Roche | Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof |
JP4058507B2 (ja) | 1997-07-10 | 2008-03-12 | 国立大学法人 東京医科歯科大学 | 4,5−ジヒドロ−[1H]−ベンズ[g]インダゾール−3−カルボン酸誘導体 |
US6191170B1 (en) * | 1998-01-13 | 2001-02-20 | Tularik Inc. | Benzenesulfonamides and benzamides as therapeutic agents |
US6136971A (en) * | 1998-07-17 | 2000-10-24 | Roche Colorado Corporation | Preparation of sulfonamides |
CA2315614C (en) * | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
WO2001046156A1 (en) * | 1999-12-22 | 2001-06-28 | Actelion Pharmaceuticals Ltd. | Butyne diol derivatives |
US6720322B2 (en) | 1999-12-22 | 2004-04-13 | Actelion Pharamceuticals Ltd. | Butyne diol derivatives |
WO2001081338A1 (en) * | 2000-04-25 | 2001-11-01 | Actelion Pharmaceuticals Ltd | Substituted sulfonylaminopyrimidines |
US6387915B2 (en) | 2000-05-31 | 2002-05-14 | Pfizer Inc. | Isoxazole-sulfonamide endothelin antagonists |
US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
US8463964B2 (en) * | 2009-05-29 | 2013-06-11 | Invensys Systems, Inc. | Methods and apparatus for control configuration with enhanced change-tracking |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW270116B (es) * | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
TW287160B (es) * | 1992-12-10 | 1996-10-01 | Hoffmann La Roche | |
TW394761B (en) * | 1993-06-28 | 2000-06-21 | Hoffmann La Roche | Novel Sulfonylamino Pyrimidines |
IL111959A (en) * | 1993-12-17 | 2000-07-16 | Tanabe Seiyaku Co | N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them |
CZ260596A3 (en) * | 1995-10-12 | 1997-12-17 | Hoffmann La Roche | Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof |
-
1996
- 1996-09-05 CZ CZ962605A patent/CZ260596A3/cs unknown
- 1996-09-23 TW TW085111636A patent/TW438779B/zh not_active IP Right Cessation
- 1996-09-30 TR TR96/00778A patent/TR199600778A2/xx unknown
- 1996-10-01 MA MA24359A patent/MA23980A1/fr unknown
- 1996-10-04 CA CA002187130A patent/CA2187130C/en not_active Expired - Fee Related
- 1996-10-07 HU HU9602748A patent/HUP9602748A3/hu unknown
- 1996-10-07 NZ NZ299519A patent/NZ299519A/en unknown
- 1996-10-07 US US08/726,712 patent/US5856484A/en not_active Expired - Fee Related
- 1996-10-07 ZA ZA968451A patent/ZA968451B/xx unknown
- 1996-10-07 IL IL11937196A patent/IL119371A/en not_active IP Right Cessation
- 1996-10-08 CN CN96113071A patent/CN1115339C/zh not_active Expired - Fee Related
- 1996-10-09 PE PE1996000714A patent/PE17098A1/es not_active Application Discontinuation
- 1996-10-10 BR BRPI9605046-2A patent/BR9605046B1/pt not_active IP Right Cessation
- 1996-10-10 AR ARP960104691A patent/AR004215A1/es active IP Right Grant
- 1996-10-10 UY UY24346A patent/UY24346A1/es unknown
- 1996-10-10 CO CO96054000A patent/CO4770959A1/es unknown
- 1996-10-11 JP JP8269962A patent/JP2723496B2/ja not_active Expired - Fee Related
- 1996-10-11 PL PL96316486A patent/PL316486A1/xx unknown
- 1996-10-11 AU AU68172/96A patent/AU706748B2/en not_active Ceased
- 1996-10-11 MX MX9604762A patent/MX9604762A/es not_active IP Right Cessation
- 1996-10-11 NO NO964334A patent/NO308000B1/no not_active IP Right Cessation
- 1996-10-12 SG SG1996010855A patent/SG46753A1/en unknown
- 1996-10-14 DK DK96116409T patent/DK0768304T3/da active
- 1996-10-14 EP EP96116409A patent/EP0768304B1/de not_active Expired - Lifetime
- 1996-10-14 PT PT96116409T patent/PT768304E/pt unknown
- 1996-10-14 ES ES96116409T patent/ES2175006T3/es not_active Expired - Lifetime
- 1996-10-14 DE DE59609225T patent/DE59609225D1/de not_active Expired - Lifetime
- 1996-10-14 AT AT96116409T patent/ATE217867T1/de not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE17098A1 (es) | Nuevas sulfonamidas | |
ATE145898T1 (de) | Verwendung von sulfonamiden als heilmittel und neue sulfonamide | |
DE10299047I2 (de) | Sulfonamide, ihre Herstellung und Verwendung als Heilmittel und Zwischenprodukte | |
PE111299A1 (es) | Derivados de n-aroilfenilalanina | |
DE69528198D1 (de) | Aryl-und hetaryl-sulfonamid derivate, deren herstellung und deren verwendung als endothelin-antagonisten | |
DK359687A (da) | Angiotensin-ii-receptor-blokerende imidazoler | |
ATE68495T1 (de) | 4,5,6,7-tetrahydro-1h-imidazo(4,5c>pyridinderivate und analoge mit antihypertensiver wirkung. | |
DE69034103D1 (de) | Imidazoalkensäure | |
ES2062403T3 (es) | 5-((tetrazolil)-alquenil)-imidazoles sustituidos. | |
PE20001419A1 (es) | COMPLEJO DEL INHIBIDOR DE RAS-FARNESILTRANSFERASA Y SULFOBUTILETER-7-ß-CICLODEXTRINA O 2-HIDROXIPROPIL-ß-CICLODEXTRINA Y METODO | |
FI811373L (fi) | Substituerade fenyletrar | |
ES2159749T3 (es) | Derivados de bencilamino-2-metil-propanamidas 2-(4-sustituidas). | |
FI905481A0 (fi) | Substituerade n-(imidazolyl) -alkylalaninderivat. | |
FI852003A0 (fi) | --laktamantibiotika, foerfarande foer deras framstaellning och deras anvaendning som laekemedel eller tillvaextbefraemjare vid boskapsuppfoedning eller som antioxidanter. | |
PE20020333A1 (es) | Derivados de pirrolidina como inhibidores de la enzima conversor de endotelina | |
PE86698A1 (es) | Derivados de indolina | |
UY23428A1 (es) | Procedimiento para la preparacion de nuevas sulfonamidas | |
DE3782190D1 (de) | Antihypertensives mittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |